mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1

Por Schickel, Robert, Park, Sun-Mi, Murmann, Andrea E., Peter, Marcus E.
Publicado em 2010

DISE - A Seed Dependent RNAi Off-Target Effect that Kills Cancer Cells

Por Putzbach, William, Gao, Quan Q., Patel, Monal, Haluck-Kangas, Ashley, Murmann, Andrea E., Peter, Marcus E.
Publicado no Trends Cancer (2018)

Molecular Ordering of the Initial Signaling Events of CD95

Por Algeciras-Schimnich, Alicia, Shen, Le, Barnhart, Bryan C., Murmann, Andrea E., Burkhardt, Janis K., Peter, Marcus E.
Publicado em 2002

miRConnect: Identifying Effector Genes of miRNAs and miRNA Families in Cancer Cells

Por Hua, Youjia, Duan, Shiwei, Murmann, Andrea E., Larsen, Niels, Kjems, Jørgen, Lund, Anders H., Peter, Marcus E.
Publicado em 2011

MicroRNAs Reprogram Normal Fibroblasts into Cancer Associated Fibroblasts in Ovarian Cancer

Por Mitra, Anirban K., Zillhardt, Marion, Hua, Youjia, Tiwari, Payal, Murmann, Andrea E., Peter, Marcus E., Lengyel, Ernst
Publicado em 2012

Inverted duplications on acentric markers: mechanism of formation

Por Murmann, Andrea E., Conrad, Donald F., Mashek, Heather, Curtis, Chris A., Nicolae, Raluca I., Ober, Carole, Schwartz, Stuart
Publicado em 2009

CD95 and CD95L promote and protect cancer stem cells

Por Ceppi, Paolo, Hadji, Abbas, Kohlhapp, Frederick J., Pattanayak, Abhinandan, Hau, Annika, Liu, Xia, Liu, Huiping, Murmann, Andrea E., Peter, Marcus E.
Publicado no Nat Commun (2014)

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1

Por Boyerinas, Benjamin, Park, Sun-Mi, Murmann, Andrea E., Gwin, Katja, Montag, Anton G., Zillardt, Marion R., Hua, You-Jia, Lengyel, Ernst, Peter, Marcus E.
Publicado em 2011

Induction of DISE in ovarian cancer cells in vivo

Por Murmann, Andrea E., McMahon, Kaylin M., Haluck-Kangas, Ashley, Ravindran, Nandini, Patel, Monal, Law, Calvin Y., Brockway, Sonia, Wei, Jian-Jun, Thaxton, C. Shad, Peter, Marcus E.
Publicado no Oncotarget (2017)

Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells

Por Murmann, Andrea E, Gao, Quan Q, Putzbach, William E, Patel, Monal, Bartom, Elizabeth T, Law, Calvin Y, Bridgeman, Bryan, Chen, Siquan, McMahon, Kaylin M, Thaxton, C Shad, Peter, Marcus E
Publicado no EMBO Rep (2018)

Death Induced by CD95 or CD95 Ligand Elimination

Por Hadji, Abbas, Ceppi, Paolo, Murmann, Andrea E., Brockway, Sonia, Pattanayak, Abhinandan, Bhinder, Bhavneet, Hau, Annika, De Chant, Shirley, Parimi, Vamsi, Kolesza, Piotre, Richards, JoAnne, Chandel, Navdeep, Djaballah, Hakim, Peter, Marcus E.
Publicado em 2014

Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism

Por Putzbach, William, Gao, Quan Q, Patel, Monal, van Dongen, Stijn, Haluck-Kangas, Ashley, Sarshad, Aishe A, Bartom, Elizabeth T, Kim, Kwang-Youn A, Scholtens, Denise M, Hafner, Markus, Zhao, Jonathan C, Murmann, Andrea E, Peter, Marcus E
Publicado no eLife (2017)

CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1 Dependent Type I Interferon Response

Por Qadir, Abdul S., Ceppi, Paolo, Brockway, Sonia, Law, Calvin, Mu, Liang, Khodarev, Nikolai N., Kim, Jung, Zhao, Jonathan C., Putzbach, William, Murmann, Andrea E., Chen, Zhuo, Chen, Wenjing, Liu, Xia, Salomon, Arthur R., Liu, Huiping, Weichselbaum, Ralph R., Yu, Jindan, Peter, Marcus E.
Publicado no Cell Rep (2017)